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Abstract
Background: The Interventional Neuroradiology is becoming more important in the interdisciplinary treatment of
acute haemorrhages due to vascular erosion and vascular tumors in the head and neck area. The authors report on
acute extracranial haemorrhage in emergency situations but also on preventive embolization of good vascularized
tumors preoperatively and their outcome.
Methods: Retrospective analysis of 52 patients, who underwent an interdisciplinary approach of the ORL Department
and the Interventional Neuroradiology over 5 ½ years at the Department of Otorhinolaryngology, Klinikum Rechts der
Isar, Technical University of Munich, Germany. Their outcome was analysed in terms of success of the embolization,
blood loss, survival rate and treatment failures.
Results: 39/52 patients were treated for acute haemorrhage. Twenty-five of them attributable to vascular erosion in
case of malignant tumors. Affected vessels were the common carotid artery as well as its internal and external parts
with branches like the ascending pharyngeal, the facial and the superior thyroid artery.
Altogether 27/52 patients were treated for malignant tumors, 25/52 were attributable to acute haemorrhage due to
epistaxis, after tonsillectomy, benign tumors and bleeding attributable to inflammations. Treatment of all patients
consisted either of an unsuccessful approach via exposure, package of the bleeding, electrocoagulation or surgical
ligature followed by embolization or the primary treatment via interventional embolization/stenting.
Conclusions: The common monitoring of patients at the ORL and interventional neuroradiology is an important
alternative especially in the treatment of severe acute haemorrhage, following vascular erosion in malignant tumors or
benign diseases. But also the preoperative embolization of good vascularized tumors must be taken into account to
prevent severe blood loss or acute intraoperative bleeding.
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Background
The incidence of the therapeutical use of interventional
neuroradiology in the head and neck is increasing espe-
cially in acute bleeding situations. The first description of
therapeutic percutaneous embolization in intractable epi-
staxis appeared as early as 1974 [1]. Because of the intim-
ate anatomy of the extracranial and intracranial vascular
system, the treatment of acute haemorrhage and also the
preoperative treatment of hypervascular tumors by an
endovascular or transcutaneous technique is still reserved
for specific indications and, in most cases, is still not the
first choice of treatment. Classic indications may include
acute arterial haemorrhage attributable to vascular ero-
sions in carcinomas, refractory epistaxis or bleeding after
tonsillectomy. But also the preoperative “downstaging” of
benign and malign tumors represents a considerable
amount of cases, in order to prevent severe blood loss or
intraoperative haemorrhage. We present a retrospective
study of 52 patients who attended the Department of Oto-
laryngology (ORL) of the Technical University of Munich
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(TUM) and who underwent intra-arterial embolization
treatment at the Department of Interventional Neuroradi-
ology, TUM, during a time span of January 2007 to May
2012 (5 ½ years).
Methods
Patients
Data were collected during a 5.5-year period. Charts were
reviewed for demographics, range of indications for
embolization, tumor localization and size, initial onco-
logical treatment, localization of bleeding, tumor recur-
rence, survival outcome (Munich cancer register) and
failure rates of the embolization. All research has been ap-
proved by the authors’ ethic committee of the Technical
University of Munich (Permit Number: 251/15). Fifty-two
patients underwent interventional procedures including
selective angiographic or transcutaneous embolization/
stenting. The mean age of the entire cohort was 54.9 ±
19.7 years (Range 11–94 years). Of these patients, 35 were
male and 17 were female; 38 patients presented with tu-
mors (n = 27 malignant tumors, n = 11 benign tumors),
nine patients with refractory epistaxis, three patients with
refractory bleeding after tonsillectomy and two patients
with bleeding because of inflammation.
The mean age of 64.8 ± 11.8 years was the highest in
patients with malignant tumors and the lowest with
27.3 ± 4.8 years in patients with bleeding after tonsillec-
tomy. Patients of the ORL, who underwent other intra-
cranial interventions, e.g. attributable to apoplexy, were
excluded.
Embolization
Generally, percutaneous embolization was performed
under general anaesthesia after imaging diagnostics such
as magnetic resonance imaging (MRI) or computerized
tomography (CT)-scan. In every case a guiding catheter
(e.g. 6 F Envoy® [Codman]) was positioned supra-aortic in
the internal carotid artery (ICA), external carotid artery
(ECA), vertebral artery (VA) or branches of the thyrocer-
vical trunk by a transfemoral, transarterial access over a
hydrophilic guide wire (e.g. 0.35 Glidewire® [Terumo]).
The bleeding or the pathological vessels could be localized
by injection of a contrast agent (Imeron 300® [Bracco])
into the vessels. In cases of solid tumorous masses with a
subcutaneous or intranasal superficial localization, direct
transcutaneous or transnasal respectively puncture was
considered; therefor a 20 G, 88 mm coaxial needle (Spino-
can® [B.Braun]) was placed under biplane fluoroscopy by
means of a transarterial “roadmap”. The correct position
was checked by an injection of contrast agent directly
through the needle. If the ICA ran nearby the target lesion
a balloon was temporarily inflated in the ICA to prevent
embolization of the liquid into intracranial vessels (Coper-
nic®, BALT).
In cases of a more diffuse bleeding or multiple rather
separated affected vessels the intra-arterial access was
the approach of choice, in doing so a microcatheter
(Prowler select® [Codman], Nautica™, Rebar™, Echelon™,
Marathon™, Apollo™ [ev3]) was delivered to the target
vessel over a microwire (syncro2standard® [Boston scien-
tific], Traxcess® [Microvention]).
Embolization liquids were synthetic glue (Glubran2,
[GEM S.r.l.], Histoacryl® [B. Braun]) diluted with an oily
contrast agent (Lipiodol®UltraFluid [Guerbet]) at a ratio
of 1:3 or an ethylene vinyl alcohol copolymer dissolved
in dimethyl sulfoxide (Onyx®LES [Covidien]). Solid
embolization devices were polyvinyl alcohol (PVA) parti-
cles of different sizes (150–355, 250–350, 500–700 μm;
BeadBlock™ [Terumo]; Contour™ [Boston Scientific]) or
bare metal coils (Axium™, Helix™ Coils, [ev3]; Delta-
plush™ [Codman]), fibered coils (Helix™Fibered Coils,
[ev3]) respectively. In three cases stent grafts (Fluency®
[BARD]) were implanted in the common carotid artery,
in one of these patients five days later the same vessel
was occluded with vascular plugs (Amplatzer® [St.Jude
Medical]) proximal and distal of the lesion.
Results
Acute versus elective embolization
39/52 patients (75 %) developed acute arterial haemorrhage.
In 25 cases due to vascular erosion in malignant tumors,
followed by refractory epistaxis (n = 9) and haemorrhage
after tonsillectomy (n = 3). Only one benign tumor and one
haemorrhage due to inflammation led to an acute interven-
tion. Figure 1 shows the distribution of emergency and
elective embolization depending on the diagnosis. Espe-
cially with respect to the emergency embolization of acute
haemorrhage, 34/39 were successful and five unsuccessful
in terms of stopping the haemorrhage.
13/52 patients underwent elective intra-arterial embo-
lization mostly to prevent intraoperative severe blood loss
due to good vascularized tumors. The elective embolization
was successful in 9/13 cases in terms of “downstaging” the
vascularization and successful resection of the tumor within
48 h after the embolization and failed in four cases all due
to the lack of feeding vessels.
Figure 2 shows the success rate based on the diagno-
sis. One benign tumor resulted in a papilloma without
feeding vessels. Seven failures occurred in malignant
tumors, of which no feeding vessels could be detected
in five cases, a palliative and only uncompleted embo-
lization via direct puncture could be accomplished in
one case and no stable embolization position could be
found in one case. The last case was an unclear
pharyngeal bleeding without feeding vessels with
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spontaneous suspension.Table 1 shows the reasons for
the failure of the embolization.
Malignant tumors
27/52 patients were treated for malignant tumors, 25/27
of them for acute haemorrhage. Only two patients were
treated for the preoperative downstaging of malignant
tumors; 21/27 patients presented with head and neck
squamous cell carcinoma (HNSCC) classified T1 through
T4, three with thyroid carcinoma and three with other
malignant tumors. Of the 21 HNSCC, 12 presented oro-
pharyngeally, three hypopharyngeally, three laryngeally,
one oro-, hypopharyngeally (2-stage carcinoma) and one
oro-, hypopharyngeally and laryngeally (3-stage carcin-
oma). In four patients, bleeding came from the primary
tumor (initial diagnosis). In 18 cases, the bleeding was
attributable to a recurrence of the primary tumor
(three thyroid carcinomas, 15 HNSCC). Only three pa-
tients presented with haemorrhage without histological
evidence of a recurrence of the tumor. In two patients
the preoperative attempt to downstage the tumor by
embolization was used without success, due to missing
pathological afferent vessels. Of the 21 HNSCC pa-
tients, 13 developed acute arterial haemorrhage after
primary radiotherapy, seven after surgery with adju-
vant radiotherapy and only one patient after primary
surgery. We also analysed the embolized vessels. A
total of 36 vessels were embolized/stented: in 31 cases,
branches of the external carotid artery (12 times super-
ior and inferior thyroid artery) and in five cases,
branches of the subclavian artery.
Due to a tumorous erosion of the common carotid
artery a covered fluency stent graft was used for the re-
construction in two cases. Another covered fluency stent
































Fig. 1 Distribution of diagnosis-related emergency versus elective embolization
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graft was used for an erosion of the common carotid ar-
tery due to a chronical inflammation.
With the assistance of the Munich Cancer Register we
also obtained data concerning the survival rate of all
tumor patients. The long-term follow-up of a maximum
of 60 months post-interventional showed an overall sur-
vival rate of 38 % (Fig. 3).
Benign tumors
Eleven patients were treated for benign tumors pre-
operatively by embolization in order to minimize the
vascularization and the intra-surgery bleeding. 10/11
underwent preoperative embolization, one an acute
intervention due to acute intraoperative bleeding. Four
patients had tumors of the glomus caroticum. All pa-
tients described an increasing not painful swelling of
the neck.
Three young male patients with juvenile nasopharyngeal
angiofibromas describing the typical symptoms as nose
blockade, swelling of the face, headache or epistaxis. In all
three patients the preoperative embolization of the tumors
resulted in a satisfying resectability of the nasopharyngeal
angiofibroma via midfacial degloving without remarkable
side effects. Within the follow-up time span of this re-
search none of these young patients presented with the re-
currence of the tumor. Two patients presented with
haemangioma with a progredient swelling of the temporal
or submandibular region and one each of papilloma and
chondroma. In Fig. 4, the preoperative MRI scans of a 17-
year-old boy with a juvenile nasopharyngeal angiofibroma
are shown. Figure 5 shows the embolization via direct
puncture of the tumor.
Epistaxis
All patients (n = 9) who underwent emergency intra-
arterial embolization for epistaxis were first treated con-
servatively via nasal packing and/or cautery under local
anaesthesia and local vasoconstrictors or under general
anaesthesia via endoscopic surgery or by septumplasty, all
without success. In eight cases, posterior epistaxis could
be seen. In one case, an anterior/ posterior epistaxis in a
patient with Osler’s disease could be detected. In seven
cases, the sphenopalatine artery was embolized, in one
case the maxillary artery, in one case the ascending palat-
ine artery and in one case the descending palatine artery.
Three of the patients suffered from hypertension, two of
them being additionally treated with anticoagulants. One
patient suffered from Osler’s disease and is well known in
our department, since he presents with epistaxis at fre-
quent intervals.
Haemorrhage after tonsillectomy
Three patients presented with severe haemorrhage after
tonsillectomy. None of them were operated upon in our
department. All three cases were refractory to the pri-
mary attempt of operative haemostasis through the oral
cavity under general anaesthesia via ligation, cautery and
oral packing. As in all three cases the colleagues of the
interventional neuroradiology were already prepared for
a possible intervention, embolization of the arteries was
performed immediately after the operation, instead of li-
gating the external carotid artery via a cervical approach.
The facial artery was embolized with success and neck
surgery to prepare and ligate the carotid artery or it’s
branches was not necessary.
Blood loss
Malignant tumors
We additionally analysed the blood loss as it is one of the
main reasons for the intervention to be considered. Con-
cerning the malignant tumors, the blood loss due to acute
haemorrhage was high. Of 27 patients, 15 were unsuccess-
fully treated by surgical haemostasis primarily. In three
patients, no blood transfusion was needed. In these cases
the preoperative haemoglobin level was 11.0 (±1.5) [g/dL]
and 10.1 (±2.0) [g/dL] after the unsuccessful surgery. The
preoperative haemoglobin level of the other twelve pa-
tients was 9.0 (±2.5) [g/dL] and postoperatively 9.2 (±2.3)
[g/dL]. These twelve patients all together received 16
fresh frozen plasma and 74 red cell concentrates. 12
patients were treated by primary embolization without
a primary surgical intent due to the dramatic bleeding.
10/14 did not receive blood transfusion since the
haemoglobin level before the embolization was 12.2
(±1.9) [g/dL] and after the procedure 10.9 (±2.0) [g/
dL]. In two patients, a blood transfusion was needed.
The haemoglobin level was 9.8 (±1.0) [g/dL] before
and 11.1 (±2.3) [g/dL] after the embolization. These
two patients received twelve red cell concentrates all
together.
Benign tumors
Especially in the preventive preoperative embolization of
good vascularized benign tumors, the minimization of
Fig. 3 Long-term follow-up of a maxiumum of 60 months shows a
overall survival rate of 38 % of all tumor patients
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Fig. 4 Preoperative MRI Scan of a 17-year-old boy with a juvenile nasopharyngeal angiofibroma: a shows the axial view and b shows the coronary scan
Fig. 5 Embolization of the juvenile nasopharyngeal angiofibroma via direct puncture, all in lateral view: a pre-interventional digital subtraction
angiography. b example of the needle position in lateral view. c post-interventional control via digital subtraction angiography. d post-interventional
digital subtraction angiography without image subtraction
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the intraoperative blood loss and the occurrence of an
acute intra- or postoperative bleeding was a major issue
of the embolization. One was primarily treated surgically
and afterwards by embolization due to acute intraopera-
tive bleeding. In this case, the preoperative haemoglobin
level was 15 [g/dL] and after the operation 12.2 [g/dL].
Before embolization, we measured a value of 12.2 [g/dL]
and afterwards a value of 9.4 [g/dL]. Hence, blood loss
in total was 5.6 [g/dL]. 10/11 benign tumors received a
preoperative embolization of the tumor. In eight cases,
no blood transfusion was needed. The haemoglobin level
before the embolization was 13.4 (±1.1) [g/dL] and after
the embolization 12.3 (±1.9) [g/dL]. Surgical procedures
were then performed within 48 h. The haemoglobin level
was then preoperatively 14.3 (±0.8) [g/dL] and after the
surgery 13.4 (±1.1) [g/dL]. In two cases, blood transfu-
sion intraoperatively was necessary (one tumor of the
glomus caroticum and one juvenile nasopharyngeal
angiofibroma). Here, the haemoglobin level was 13.0
[g/dL] and after the embolization 12.1 [g/dL]. Before
surgery, the haemoglobin level was 11.4 [g/dL] and
after surgery and three erythrocyte concentrates 8.1
[g/dL].
One special case that needs to be mentioned was a
young girl following the ingestion of an alkali liquid in
an attempt of suicide and a subsequent infection of the
neck due to recurrent fistulas. A severe haemorrhage of
the common carotid artery attributable to inflammation
occurred with dramatic blood loss. The preoperative
haemoglobin level was 9.1 [g/dL] and postoperative 6.5
[g/dL] after 20 RCCs (red cell concentrates) and 20
packed blood plasma.
The Table 2 shows the total need of RBCs and blood
plasma.
Selective angiography and embolization versus direct
puncture
In 52 patients, 44 received selective angiography and
embolization or stenting due to active haemorrhage.
Only 8 % were treated by direct puncture of the tumor.
All of them were elective preoperative procedures (6 be-
nign tumors, 2 malign tumors) for the minimization of
the vasculature. Table 3 shows the distribution between
the two strategies relating to the diagnosis.
Since various materials for the embolization or stent-
ing of vessels are available, we also determined the fre-
quencies of these possibilities. In total, materials were
used in 45 cases. In seven cases, bare metal coils were
used, in nine cases a mixture of acrylic glue (Glubran2®:-
Lipidol (1:3)), in one case ethylene vinyl alcohol (Onyx®)
and in three cases fibre coils. To ensure the patency of
the carotids and to seal the outgoing vessels, covered
stentgrafts (Fluency®) were used in two patients. In all
other cases (n = 23), combinations of the above-mentioned
materials were employed. No statistical significance was
seen between the different materials, the outcome
concerning the haemorrhage and the complications
and side effects.
Table 2 Diagnosis-related need of RBCs and blood plasma
Total number of
patients [n] = 52
Number of patients
with transfusions [n] = 21
Amount of RCC’s
[n] = 120
Amount of fresh frozen
plasma [n] = 32
Epistaxis 9 3 8 2
Haemorrhage after tonsillectomy 3 2 3 0
Benign tumors 11 2 3 0
Malign tumors 27 14 86 16
Haemorrhage attributable to inflammation 2 1 20 14
Table 1 Reasons for the failure of embolization
Dignity Diagnosis Reason for failure
Benign tumor Papilloma of the soft palate No feeding vessel
Malign tumor Hypopharyngeal HNSCC Palliative and incomplete embolization via direct puncture
CUP-Syndrom No feeding vessel
Oropharyngeal HNSCC No feeding vessel
Oropharyngeal HNSCC No feeding vessel
Plasmozytoma of the sphenoid sinus No feeding vessel
Oropharyngeal HNSCC No feeding vessel
Oropharyngeal HNSCC No stable embolization position
Hemorrhage due to inflammation No feeding vessel with spontaneous suspension of the bleeding
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Discussion
In situations of acute haemorrhage and the preoperative
management of vascular tumors in the extracranial head
and neck area, an interdisciplinary approach of head and
neck surgeons and interventional neuroradiologists some-
times offers the best therapy options. However, the selec-
tion of those patients who are suitable for this approach
requires deep considerations of the pros and cons con-
cerning their risk profile. The insertion of a microcatheter
into the tumor or haemorrhage feeding vessels and the
following embolization via various materials under general
anaesthesia requires wide experience and a profound
knowledge of the anatomy. In particular, anastomoses be-
tween the extracranial and intracranial circulations are po-
tentially dangerous and, hence, a thorough knowledge of
anatomy is essential to minimize the risk of cranial nerve
palsies, blindness or stroke to name just a few. Liquid
agents and small particles of < 150 μm should be used
with caution because of the previously mentioned risks
[2]. Our aim was to provide a broad analysis of all the data
from 52 patients who underwent interventional proce-
dures as an interdisciplinary approach between the ORL
and Department of Interventional Neuroradiology of the
“Klinikum Rechts der Isar”, Technical University of
Munich, during a 5.5-year period. The data obtained in this
analysis comprises a rather heterogeneous patient popula-
tion. The same applies to the choice of embolization mater-
ial and interventional radiological techniques used. Taking
into account that situations of acute haemorrhages are pre-
dominant with 75 % a continuous and recurring workflow
could not be abstracted from the medical records. Unfortu-
nately, this study is addressing a question which is for clin-
ical an ethical reasons not transferable in a blinded and
controlled trail and so has to deal with the limitations of
retrospective gained data. To our knowledge there is no
comparable data published so far.
The indications for interventional radiology can be di-
vided into three categories [3]. The first category includes
acute haemorrhage such as acute carotideal bleeding and
also epistaxis. The carotid blowout can be defined as
“bleeding from the carotid artery or its branches” and is
one of the most feared complications, especially in
advanced head and neck malignancy, whether treated sur-
gically or with radiotherapy [4]. In our cohort, three pa-
tients suffered from tumors or inflammatory diseases
which spreaded straight to the carotid arteries. The sec-
ond category includes vascular lesions (e.g. tumors such
as haemangioma, paraganglioma or juvenile nasopharyn-
geal angiofibroma or arteriovenous malformations and
fistulas). The third category includes venous sampling for
parathyroid hormones in the diagnostics of primary
hyperparathyroidism, which is not considered in this
paper [3]. Another field is the intra-arterial chemo-
embolization of oral and oropharyngeal cancer, which is
also not considered in this study because of the lack of pa-
tients treated by this option [5].
In our cohort nine patients (17 %) were treated for re-
fractory epistaxis by embolization. Compared with an
average of 669 (±24.8) patients a year presenting to our
service with moderate to severe epistaxis and 31 of them
who needed treatment under general anesthesia, the
total number of nine patients in 5.5 years is small. We
think it is a good alternative especially in posterior epi-
staxis but as shown by the results it is reserved to special
refractory bleeding which can not be stopped even by an
endonasal surgical approach circumventing an extracra-
nial approach. We have not seen any of the complica-
tions described in the literature such as apoplexy, facial
nerve paresis, blindness or haematomas [6]. However, a
total amount of nine is too small for a reliable statement
to be made. Based on long-term follow-up, we had to
exclude one patient with Osler’s disease who repeatedly
presents to us with epistaxis. Nevertheless, the interven-
tional embolization in the case of refractory epistaxis
can be a secure and effective alternative [7–9].
Consistent with the literature, the occurrence of refrac-
tory bleeding after tonsillectomy needing to be treated by
embolization is extremely low [10]. From an average of 79
(±19.53) patients per year presenting with haemorrhage
after tonsillectomy and 32 of them treated under general
anaesthesia, the total of three patients in 5.5 years is gladly
very low. It is a good minimal invasive alternative to the
conventional ligation of the afferent carotideal branches
by open neck surgery if available.
In benign vascular tumors in particular, the preoperative
embolization of the feeding vessels might be a good option
to minimize the risk of intraoperative bleeding and to in-
crease the possibility of resecting the whole tumor. The
embolization of nasopharyngeal angiofibromas and other
benign tumors has previously been described in the litera-
ture [11, 12]. In the case of juvenile angiofibromas, pre-
operative embolization might minimize intraoperative
bleeding. In such cases, the operation site for endoscopic
resection is clearer and the possibility for resecting the
whole tumor and minimizing the risk of recurrence is
higher. A comparison of patients with angiofibromas with
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or without preoperative embolization in 1975 showed
that, in cases of preoperative embolization, the blood loss
was halved [13].
The study of Tang et al. showed a medium range of 1 ½
litres of blood loss intraoperatively after embolization in
13 patients and only 500 ml in cases of transnasal resec-
tion. The average range of blood reserve usage was 4 l
[14]. Similar results have been shown for paragangliomas
and vascular malformations [15, 16]. Since, in our depart-
ment, all patients with the mentioned tumors are embo-
lized before the operation, we cannot compare the blood
loss with or without the preoperative embolization, but as
seen in our results only two patient needed in total three
red blood cell concentrates during surgery.
The largest number of interventions involved haemor-
rhage attributable to malignant tumors. Of 27 patients,
eight women and 19 men underwent intra-arterial or
transcutaneous embolization for oncological reasons.
Consistent with the known distribution of malignomas
in the head and neck area, 21 patients had HNSCCs
[17]. Concerning the 25 patients with haemorrhage, 21
only developed acute arterial bleeding after specific time
intervals following primary therapy. Of these patients 18
patients revealed evidence of recurrent tumor disease as
established by biopsy and imaging techniques (14 after
previous primary R(C)T and only four after previous sur-
gery and adjuvant R(C)T). Only three patients did not
present a recurrent tumor. In comparison with these
data, Greve et al. found no recurrence of tumor in all
presented 10 cases [18].
In our patients, haemorrhage in malignant tumors had
two different reasons. On the one hand, the recurrence
of the tumor in many cases might cause an infiltration
of the vessels with leakage and haemorrhage. On the
other hand, bleeding is caused by long-term effects of ir-
radiation on the vessels such as arteriosclerosis and nec-
rotizing vasculitis [19]. These late irradiation effects
might be attributable to chronic oxidative stress [20]. Es-
pecially after primary R(C)T due to inoperable tumors
the doses of the radiotherapy is higher.
In four cases, haemorrhage occurred as early as the
primary diagnosis of cancer. In these cases, the tumor
had already infiltrated the surrounding vessels causing
the bleeding.
In the long-term follow-up at 60 months, the survival
rate was still 38 %, despite the high rate of recurrent tu-
mors and the inoperability of most of the tumors. So we
can assume that the embolization/stenting of the acute
haemorrhage in malignant tumors can prolong the sur-
vival rate in some cases where the conventional surgery
has its limits. Regarding blood loss, patients with malig-
nant tumors and primary unsuccessful surgery had the
highest need of red blood cell concentrates, with 74 RBC
and 16 packs fresh frozen plasma in only twelve patients.
Conclusion
Interventional radiology has an increasingly important
position in the treatment especially of acute haemorrhages
but also vascular tumors in the head and neck area. In the
treatment of acute bleeding due to benign diseases it mini-
mizes the necessity of large incisions and in malignant
tumors it sometimes reveals a good treatment alternative
in chronical altered soft tissue due to radiotherapy or sur-
gery. The common monitoring of these patients at the
ORL, the anaesthesiologists and the Department of Inter-
ventional Radiology is necessary, especially in the treat-
ment of severe haemorrhage following not only vascular
erosion in malignant tumors, but also benign diseases
such as epistaxis. However, the indication for embolization
or stenting of the tumor or feeding vessels must be con-
sidered carefully because of specific complications.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed the study: KS, KK(1), JH, MB(2), RS. Performed the
study and analysed the data: KS, KK(1), KK(2), JH, MB(1). Wrote the paper: KS,
KK(2), KK(1), MB(2). All authors read and approved the final manuscript.
Acknowledgements
The corresponding author states no financial or other relationships with
other people or organizations, which may lead to a conflict of interest.
Author details
1Department of Otorhinolaryngology, Klinikum Rechts der Isar, Technische
Universität München, Ismaningerstrasse 22, 81675 Muenchen, Germany.
2Department of Diagnostic and Interventional Neuroradiology, Klinikum
Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675
Muenchen, Germany. 3Department of Maxillofacial Surgery,
Universitaetsklinikum Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Received: 8 May 2015 Accepted: 19 January 2016
References
1. Sokoloff J, Wickbom I, McDonald D, Brahme F, Goergen TC, Goldberger LE.
Therapeutic percutaneous embolization in intractable epistaxis. Radiology.
1974;111:285–7.
2. Cooke D, Ghodke B, Natarajan SK, Hallam D. Embolization in the head and
neck. Semin Interv Radiol. 2008;25:293–309.
3. Broomfield S, Bruce I, Birzgalis A, Herwadkar A. The expanding role of
interventional radiology in head and neck surgery. J R Soc Med.
2009;102:228–34.
4. Cohen J, Rad I. Contemporary management of carotid blowout. Curr Opin
Otolaryngol Head Neck Surg. 2004;12:110–5.
5. Kovacs AF, Turowski B. Chemoembolization of oral and oropharyngeal
cancer using a high-dose cisplatin crystal suspension and degradable starch
microspheres. Oral Oncol. 2002;38:87–95.
6. Cullen MM, Tami TA. Comparison of internal maxillary artery ligation versus
embolization for refractory posterior epistaxis. Otolaryngol Head Neck Surg.
1998;118:636–42.
7. Elden L, Montanera W, Terbrugge K, Willinsky R, Lasjaunias P, Charles D.
Angiographic embolization for the treatment of epistaxis: a review of 108
cases. Otolaryngol Head Neck Surg. 1994;111(1):44–50.
8. Moreau S, De Rugy MG, Babin E, Courtheoux P, Valdazo A. Supraselective
embolization in intractable epistaxis: review of 45 cases. Laryngoscope.
1998;108(6):887–8.
9. Siniluoto TM, Leinonen AS, Karttunen A, Karjalainen HK, Jokinen KE.
Embolization for the treatment of posterior epistaxis. An analysis of 31
cases. Arch Otolaryngol Head Neck Surg. 1993;119:837–41.
Storck et al. Head & Face Medicine  (2016) 12:6 Page 8 of 9
10. Levy EI, Horowitz MB, Cahill AM. Lingual artery embolization for severe
and uncontrollable postoperative tonsillar bleeding. Ear Nose Throat J.
2001;80:208–11.
11. Siniluoto TM, Luotonen JP, Tikkakoski TA, Leinonen AS, Jokinen KE. Value of
pre-operative embolization in surgery for nasopharyngeal angiofibroma. J
Laryngol Otol. 1993;107:514–21.
12. Tikkakoski T, Luotonen J, Leinonen S, Siniluoto T, Heikkilä O, Päivänsälo M,
et al. Preoperative embolization in the management of neck paragangliomas.
Laryngoscope. 1997;107:821–6.
13. Pletcher JD, Newton TH, Dedo HH, Norman D. Preoperative embolization of
juvenile angiofibromas of the nasopharynx. Ann Otol Rhinol Laryngol. 1975;
84:740–6.
14. Tang IP, Shashinder S, Gopala Krishnan G, Narayanan P. Juvenile
nasopharyngeal angiofibroma in a tertiary centre: ten-year experience.
Singapore Med J. 2009;50:261–4.
15. Persky MS, Berenstein A, Cohen NL. Combined treatment of head and neck
vascular masses with preoperative embolization. Laryngoscope. 1984;94:20–7.
16. Valavanis A. Preoperative embolization of the head and neck: indications,
patient selection, goals, and precautions. AJNR Am J Neuroradiol.
1986;7:943–52.
17. Wittekind C. Prognostic factors in patients with squamous epithelium
carcinoma of the head and neck area and their evaluation.
Laryngorhinootologie. 1999;78:588–9.
18. Greve J, Bas M, Schuler P, Turowski B, Scheckenbach K, Budach W, et al.
Acute arterial hemorrhage following radiotherapy of oropharyngeal
squamous cell carcinoma. Strahlenther Onkol. 2010;186:269–73.
19. Okamura HO, Kamiyama R, Takiguchi Y, et al. Histopathological examination
of ruptured carotid artery after irradiation. ORL J Otorhinolaryngol Relat
Spec. 2002;64:226–8.
20. Zhao W, Diz DI, Robbins ME. Oxidative damage pathways in relation to
normal tissue injury. Br J Radiol. 2007;80(Spec No 1):23–31.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Storck et al. Head & Face Medicine  (2016) 12:6 Page 9 of 9
